GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Cash Flow from Investing

Nortem Biogroup (XPAR:MLBIO) Cash Flow from Investing : €0.00 Mil (TTM As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Dec. 2022, Nortem Biogroup spent €0.00 Mil on purchasing property, plant, equipment. It gained €0.00 Mil from selling property, plant, and equipment. It spent €0.00 Mil on purchasing business. It gained €0.00 Mil from selling business. It spent €0.00 Mil on purchasing investments. It gained €0.00 Mil from selling investments. It paid €0.00Mil for net Intangibles purchase and sale. And it paid €0.00 Mil for other investing activities. In all, Nortem Biogroup gained €0.00 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Dec. 2022.


Nortem Biogroup Cash Flow from Investing Historical Data

The historical data trend for Nortem Biogroup's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Cash Flow from Investing Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Cash Flow from Investing
- -

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Cash Flow from Investing - -

Nortem Biogroup Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Nortem Biogroup's Cash Flow from Investing for the fiscal year that ended in Dec. 2022 is calculated as:

Nortem Biogroup's Cash Flow from Investing for the quarter that ended in Dec. 2022 is calculated as:


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2022 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nortem Biogroup  (XPAR:MLBIO) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Nortem Biogroup's purchase of property, plant, equipment for the six months ended in Dec. 2022 was €0.00 Mil. It means Nortem Biogroup spent €0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Nortem Biogroup's sale of property, plant, equipment for the six months ended in Dec. 2022 was €0.00 Mil. It means Nortem Biogroup gained €0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Nortem Biogroup's purchase of business for the six months ended in Dec. 2022 was €0.00 Mil. It means Nortem Biogroup spent €0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Nortem Biogroup's sale of business for the six months ended in Dec. 2022 was €0.00 Mil. It means Nortem Biogroup gained €0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Nortem Biogroup's purchase of investment for the six months ended in Dec. 2022 was €0.00 Mil. It means Nortem Biogroup spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Nortem Biogroup's sale of investment for the six months ended in Dec. 2022 was €0.00 Mil. It means Nortem Biogroup gained €0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Nortem Biogroup's net Intangibles purchase and sale for the six months ended in Dec. 2022 was €0.00 Mil. It means Nortem Biogroup paid €0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Nortem Biogroup's cash from discontinued investing activities for the six months ended in Dec. 2022 was 0.00 Mil. It means Nortem Biogroup paid €0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Nortem Biogroup's cash from other investing activities for the six months ended in Dec. 2022 was €0.00 Mil. It means Nortem Biogroup paid €0.00 Mil for other investing activities.


Nortem Biogroup Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines